AYTU fundamentals

Aytu BioPharma, Inc. revenue for the last year amounted to 96.67M USD, the most of which — 61.12M USD — came from its highest performing source at the moment, Aytu Bioscience, the year earlier bringing 32.68M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Aytu BioPharma, Inc. 94.61M USD, and the year before that — 60.69M USD.